:: Volume 11 - Covid 19 Supplement 1 ::
Caspian J Intern Med 2020, 11 - Covid 19 Supplement 1: 551-556 Back to browse issues page
Thrombotic events in COVID-19 patients: a case series and literature review
Zahra Javidarabshahi , Shohre Khatami , Roxana Rezazade , Neda Saeedian , Mahnaz Mozdourian
Lung Diseases Research Center, Mashhad University of Medical Science, Mashhad, Iran , mozdorianmh@mums.ac.ir
Abstract:   (3101 Views)
Background: Coronavirus disease 2019 (COVID-19) has rapidly emerged as a threatening pandemic. Clinical features of this pandemic involve a wide range of manifestations and are not completely known. Here, we present six cases of thrombotic events in patients with COVID-19.
Case presentation: In this case series, we present six patients with confirmed COVID-19, according to real-time polymerase chain reaction, who were referred to our emergency department and were found to have thrombotic events. Pulmonary thromboembolism was diagnosed in three patients by computed tomography (CT) angiography. One patient was found to have deep vein thrombosis in Doppler ultrasonography. Another patient who presented with loss of consciousness, was finally diagnosed with cerebrovascular accident using brain CT. One of the patients had developed a myocardial infarction that was evident in the electrocardiography.
Conclusion: It is ostensible that COVID-19 puts the patients at an increased risk for developing thrombotic conditions, possibly through formation of hyper-inflammatory and hyper-coagulative states. However, further prospective studies are recommended to confirm these findings.
Keywords: Coronavirus Disease 2019, Thrombosis, Myocardial Infarction, Pulmonary Thromboembolism, Venous Thrombosis
Full-Text [PDF 230 kb]   (1175 Downloads)    
Type of Study: Case Series | Subject: Infectious Diseases
Received: 2020/05/31 | Accepted: 2020/09/19 | Published: 2020/10/19



XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11 - Covid 19 Supplement 1 Back to browse issues page